LSV ASSET MANAGEMENT

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1050470 CHICAGO, IL

Position in HALO

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$110,380,815

+$21,737,022 QoQ

Shares Held

1,410,257

+2.8% QoQ

Ownership

1.24%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

#23

of 664 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 48% Shared 0% None 52%

Healthcare · as of Jun 30, 2026

LSV ASSET MANAGEMENT holds $1,914,392,782 across 14 Biotechnology names. HALO ranks #5 (5.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	2,275,145	$548,241,690
2	INCY	Incyte Corp	4,123,759	$467,469,320
3	EXEL	Exelixis, Inc.	8,146,478	$443,249,867
4	REGN	Regeneron Pharmaceuticals, Inc.	253,200	$157,880,328
5	HALO	Halozyme Therapeutics, Inc. This page	1,410,257	$110,380,815
6	HRMY	Harmony Biosciences Holdings, Inc.	2,061,242	$75,049,821
7	BMRN	Biomarin Pharmaceutical Inc	881,700	$50,450,874
8	RIGL	Rigel Pharmaceuticals Inc	721,666	$28,231,573

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$110,380,815	1,410,257	+2.8%	Shares	Sole	2026-08-06
2026-03-31	$88,643,793	1,371,558	+5.4%	Shares	Sole	2026-05-11
2025-12-31	$87,561,001	1,301,055	+2.8%	Shares	Sole	2026-02-06
2025-09-30	$92,850,420	1,266,027	+0.9%	Shares	Sole	2025-11-06
2025-06-30	$65,297,584	1,255,240	+40.2%	Shares	Sole	2025-08-11
2025-03-31	$57,122,137	895,191	+41.9%	Shares	Sole	2025-05-09
2024-12-31	$30,171,026	631,061	+0.0%	Shares	Sole	2025-02-13
2024-09-30	$36,106,992	630,800	+2.8%	Shares	Sole	2024-11-12
2024-06-30	$32,138,568	613,800	+32.9%	Shares	Sole	2024-08-06
2024-03-31	$18,786,024	461,800	-0.1%	Shares	Sole	2024-05-06
2023-12-31	$17,090,304	462,400	—	Shares	Sole	2024-02-06
No filing history on record for this holder in this stock.